A validated SIM GC/MS method for the simultaneous determination of dextromethorphan and its metabolites dextrorphan, 3‐methoxymorphinan and 3‐hydroxymorphinan in biological matrices and its application to in vitro CYP2D6 and CYP3A4 inhibition study
- 14 May 2009
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 23 (11) , 1131-1137
Abstract
Dextromethorphan is used as a probe drug for assessing CYP2D6 and CYP3A4 activity in vivo and in vitro. A SIM GC/MS method without derivatization for the simultaneous determination of dextromethorphan and its metabolites, dextrorphan, 3‐methoxymorphinan and 3‐hydroxymorphinan, in human plasma, urine and in vitro incubation matrix was developed and validated. Calibration curves indicated good linearity with a coefficient of variation (r) better than 0.995. The lower limit of quantitation was found to be 10 ng/mL for all analytes in all matrices. Intra‐day and inter‐day precision for dextromethorphan and its metabolites was better than 9.02 and 9.91%, respectively and accuracy ranged between 91.76 and 106.27%. Recovery for dextromethorphan, its metabolites and internal standard levallorphan was greater than 72.68%. The method has been successfully applied for the in vitro inhibition of metabolism of dextromethorphan by CYP2D6 and CYP3A4 using known inhibitors of CYPs such as quinidine and verapamil. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
This publication has 42 references indexed in Scilit:
- Dextromethorphan: A Review of N‐methyl‐d‐aspartate Receptor Antagonist in the Management of PainCNS Drug Reviews, 2007
- High performance liquid chromatography determination of dextromethorphan and its metabolites in urine using solid-phase extractionJournal of Pharmaceutical and Biomedical Analysis, 1996
- Simultaneous Determination of Dextromethorphan and Dextrorphan in Human Plasma, Urine and Cerebrospinal Fluid by HPLC with Fluorescence DetectionJournal of Liquid Chromatography & Related Technologies, 1996
- High-Performance Liquid Chromatography Determination of Dextromethorphan and Dextrorphan for Oxidation Phenotyping by Fluorescence and Ultraviolet DetectionTherapeutic Drug Monitoring, 1993
- The genetic polymorphism of debrisoquine/sparteine metabolism — Clinical aspectsPharmacology & Therapeutics, 1990
- The genetic polymorphism of debrisoquine/sparteine metabolism—molecular mechanismsPharmacology & Therapeutics, 1990
- Simultaneous Determination of Dextromethorphan and Three Metabolites in Plasma and Urine Using High-Performance Liquid Chromatography with Application to Their Disposition in ManTherapeutic Drug Monitoring, 1990
- Determination of dextromethorphan and its metabolites in plasma by dual column liquid chromatography and fluorimetric detectionJournal of Pharmaceutical and Biomedical Analysis, 1988
- Bioavailability Evaluation of a Controlled‐Release Dextromethorphan LiquidThe Journal of Clinical Pharmacology, 1987
- The urinary excretion of dextromethorphan and three metabolites in dogs and humansToxicology and Applied Pharmacology, 1980